The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE RELATIVE MERITS OF TRANYLCYPROMINE ALONE AND TRANYLCYPROMINE IN COMBINATION WITH TRIFLUOPERAZINE IN THE TREATMENT OF PATIENTS WITH SEVERE AGITATED DEPRESSIONS

Published Online:https://doi.org/10.1176/ajp.118.10.934

Tranylcypromine in combination with trifluoperazine is of very significant benefit in severely agitated, depressed patients. Tranylcypromine alone is of little significant worth in this type of patient.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.